Literature DB >> 23907102

Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.

Marnix C Maas1, Jurgen J Fütterer, Tom W J Scheenen.   

Abstract

OBJECTIVES: Computed diffusion-weighted magnetic resonance imaging (cDWI) refers to the synthesizing of arbitrary b value diffusion-weighted images (DWI) from a set of measured b value images by voxelwise fitting. The objectives of this study were to quantitatively analyze the noise and the contrast-to-noise ratio (CNR) in cDWI as a function of b value by numerical simulations and by measurements in patients with prostate cancer and to compare cDWI to directly measured DWI at a b value of 1400 s/mm2.
MATERIALS AND METHODS: Numerical simulations were performed to assess image noise and CNR in both cDWI and regular DWI. Forty-two patients with prostate cancer (age, 51-73 years; prostate specific antigen level, 0.5-30 ng/mL; and biopsy Gleason score, 6-9) received 2 DWI examinations at 3.0 T (one with b values of 100, 500, and 1400 s/mm2 and another with b values of 0, 100, 400, and 800 s/mm2) to create cDWI images at arbitrary b values, both with and without incorporating a b value of 0 s/mm2 in their calculation. Regions of interest were drawn to compare the scan time adjusted CNR (CNR eff) between cDWI and directly measured DWI at b = 1400 s/mm2 on tumor-suspicious lesions and normal-appearing regions.
RESULTS: In the numerical simulations, noise depended strongly on the b value, the diffusion coefficient, and the signal intensity at a b value of 0 s/mm2 in cDWI but not in regular DWI. The CNR between simulated tumor and normal regions showed a continuous increase with increasing b value. Both these findings were also observed in tumor-suspicious and normal-appearing regions in in vivo data. In vivo prostate DWI at a b value of 1400 s/mm2 showed a similar CNR eff between the tumor-suspicious regions and the normal-appearing tissue in cDWI as in the directly measured DWI (P = 0.395).
CONCLUSIONS: The CNR eff between tumor-suspicious and normal-appearing prostate tissue in DWI images at a b value of 1400 s/mm2 is comparable in cDWI and directly measured DWI. Computed DWI at even higher b values, calculated from measured images with b values between 0 and 800 s/mm2, yields higher CNR eff than measured DWI, which may be of clinical aid in the management of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907102     DOI: 10.1097/RLI.0b013e31829705bb

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  34 in total

1.  Computed diffusion-weighted MRI for prostate cancer detection: the influence of the combinations of b-values.

Authors:  Y Ueno; S Takahashi; Y Ohno; K Kitajima; M Yui; Y Kassai; F Kawakami; H Miyake; K Sugimura
Journal:  Br J Radiol       Date:  2015-01-21       Impact factor: 3.039

2.  MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?

Authors:  Salma Jendoubi; Mathilde Wagner; Sarah Montagne; Malek Ezziane; Julien Mespoulet; Eva Comperat; Candice Estellat; Amandine Baptiste; Raphaele Renard-Penna
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

Review 3.  Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.

Authors:  Berrend G Muller; Willemien van den Bos; Peter A Pinto; Jean J de la Rosette
Journal:  Curr Opin Urol       Date:  2014-05       Impact factor: 2.309

4.  Diffusion-weighted imaging of the prostate: should we use quantitative metrics to better characterize focal lesions originating in the peripheral zone?

Authors:  Thibaut Pierre; Francois Cornud; Loïc Colléter; Frédéric Beuvon; Frantz Foissac; Nicolas B Delongchamps; Paul Legmann
Journal:  Eur Radiol       Date:  2017-11-22       Impact factor: 5.315

5.  Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.

Authors:  S Feuerlein; M S Davenport; A Krishnaraj; E M Merkle; R T Gupta
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-03       Impact factor: 5.554

6.  Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.

Authors:  Jiejie Zhou; Endong Chen; Huazhi Xu; Qiong Ye; Jiance Li; Shuxin Ye; Qinyuan Cheng; Liang Zhao; Min-Ying Su; Meihao Wang
Journal:  J Magn Reson Imaging       Date:  2018-10-16       Impact factor: 4.813

7.  Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?

Authors:  D Hausmann; N Aksöz; J von Hardenberg; T Martini; N Westhoff; S Buettner; S O Schoenberg; P Riffel
Journal:  Eur Radiol       Date:  2017-08-10       Impact factor: 5.315

8.  Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer.

Authors:  Kinzya B Grant; Harsh K Agarwal; Joanna H Shih; Marcelino Bernardo; Yuxi Pang; Dagane Daar; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Abdom Imaging       Date:  2015-03

9.  Quantitative evaluation of computed and voxelwise computed diffusion-weighted imaging in breast cancer.

Authors:  Qingyuan Cheng; Shuxin Ye; Chuqi Fu; Jiejie Zhou; Xiaxia He; Haiwei Miao; Nina Xu; Meihao Wang
Journal:  Br J Radiol       Date:  2019-07-10       Impact factor: 3.039

10.  Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.

Authors:  Yin Xi; Alexander Liu; Franklin Olumba; Parker Lawson; Daniel N Costa; Qing Yuan; Gaurav Khatri; Takeshi Yokoo; Ivan Pedrosa; Robert E Lenkinski
Journal:  Quant Imaging Med Surg       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.